AMPAkines have novel analgesic properties in rat models of persistent neuropathic and inflammatory pain

Anesthesiology

Volumn 121, Issue 5, 2014, Pages 1080-1090

  Le, Alexander M ^a   Lee, Michelle ^a   Su, Chen ^b   Zou, Anthony ^c   Wang, Jing ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 BENZODIOXAN 6 CARBOXYLIC ACID PIPERIDIDE; 6 QUINOXALINECARBOXYLIC ACID PIPERIDIDE; AMPA RECEPTOR; ANALGESIC AGENT; DIMETHYL SULFOXIDE; FREUND ADJUVANT; 1,3 DIOXOLANE DERIVATIVE; 1-(1,4-BENZODIOXAN-6-YLCARBONYL)PIPERIDINE; 1-(QUINOXALIN-6-YLCARBONYL)PIPERIDINE; ANTIDEPRESSANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PIPERIDINE DERIVATIVE;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG EFFICACY; FORCED SWIM TEST; IMMOBILIZATION; INFLAMMATORY PAIN; LOCOMOTION; MALE; NERVE INJURY; NEUROPATHIC PAIN; NONHUMAN; PERIPHERAL NEUROPATHY; POSTOPERATIVE PAIN; RAT; RESPIRATORY DRIVE; SCORING SYSTEM; STARTLE REFLEX; ANIMAL; ANIMAL BEHAVIOR; CHEMICALLY INDUCED; DRUG EFFECTS; INFLAMMATION; MOTOR ACTIVITY; NEURALGIA; PAIN MEASUREMENT; PSYCHOLOGY; SPRAGUE DAWLEY RAT; SWIMMING;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; DIOXOLES; INFLAMMATION; MALE; MOTOR ACTIVITY; NEURALGIA; PAIN MEASUREMENT; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; SWIMMING;

EID: 84914148411     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000000351     Document Type: Article

References (82)

1. Dahan A, Overdyk F, Smith T, Aarts L, Niesters M: Pharmacovigilance: A review of opioid-induced respiratory depression in chronic pain patients. Pain Physician 2013; 16:E85-94
2. Dahan A, Aarts L, Smith TW: Incidence, reversal, and prevention of opioid-induced respiratory depression. Anest hesiolo gy 2010; 112:226-38
3. Benyamin R, Trescot AM, Datta S, Buenaventura R, Adlaka R, Sehgal N, Glaser SE, Vallejo R: Opioid complications and side effects. Pain Physician 2008; 11(2 suppl):S105-20
4. Paulozzi LJ, Budnitz DS, Xi Y: Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf 2006; 15:618-27
5. Song I, Huganir RL: Regulation of AMPA receptors during synaptic plasticity. Trends Neurosci 2002; 25:578-88
6. Park JS, Yaster M, Guan X, Xu JT, Shih MH, Guan Y, Raja SN, Tao YX: Role of spinal cord alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors in complete Freund's adjuvant-induced inflammatory pain. Mol Pain 2008; 4:67
7. Stanfa LC, Dickenson AH: The role of non-N-methyl-d-Aspartate ionotropic glutamate receptors in the spinal transmission of nociception in normal animals and animals with carrageenan inflammation. Neuroscience 1999; 93:1391-8
8. H artmann B, Ahmadi S, Heppenstall PA, Lewin GR, Schott C, Borchardt T, Seeburg PH, Zeilhofer HU, Sprengel R, Kuner R: The AMPA receptor subunits GluR-A and GluR-B reciprocally modulate spinal synaptic plasticity and inflammatory pain. Neuron 2004; 44:637-50
9. Katano T, Furue H, Okuda-Ashitaka E, Tagaya M, Watanabe M, Yoshimura M, Ito S: N-ethylmaleimide-sensitive fusion protein (NSF) is involved in central sensitization in the spinal cord through GluR2 subunit composition switch after inflammation. Eur J Neurosci 2008; 27:3161-70
10. Lu Y, Sun YN, Wu X, Sun Q, Liu FY, Xing GG , Wan Y: Role of alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor subunit GluR1 in spinal dorsal horn in inflammatory nociception and neuropathic nociception in rat. Brain Res 2008; 1200:19-26
11. Chen J, Song Y, Yang J, Zhang Y, Zhao P, Zhu XJ, Su HC: The contribution of TNF-A in the amygdala to anxiety in mice with persistent inflammatory pain. Neurosci Lett 2013; 541:275-80
12. Li W, Neugebauer V: Block of NMDA and non-NMDA receptor activation results in reduced background and evoked activity of central amygdala neurons in a model of arthritic pain. Pain 2004; 110:112-22
13. Xu H, Wu LJ, Wang H, Zhang X, Vadakkan KI, Kim SS, Steenland HW, Zhuo M: Presynaptic and postsynaptic amplifications of neuropathic pain in the anterior cingulate cortex. J Neurosci 2008; 28:7445-53
14. van Praag H, Frenk H: The role of glutamate in opiate descending inhibition of nociceptive spinal reflexes. Brain Res 1990; 524:101-5
15. Spinella M, Cooper ML, Bodnar RJ: Excitatory amino acid antagonists in the rostral ventromedial medulla inhibit mesencephalic morphine analgesia in rats. Pain 1996; 64:545-52
16. Urban MO, Coutinho SV, Gebhart GF: Involvement of excitatory amino acid receptors and nitric oxide in the rostral ventromedial medulla in modulating secondary hyperalgesia produced by mustard oil. Pain 1999; 81:45-55
17. G halandari-Shamami M, Hassanpour-Ezatti M, Haghparast A: Intra-Accumbal NMDA but not AMPA/kainate receptor antagonist attenuates WIN55,212-2 cannabinoid receptor agonistinduced antinociception in the basolateral amygdala in a rat model of acute pain. Pharmacol Biochem Behav 2011; 100:213-9
18. G ear RW, Aley KO, Levine JD: Pain-induced analgesia mediated by mesolimbic reward circuits. J Neurosci 1999; 19:7175-81
19. Arai AC, Kessler M: Pharmacology of ampakine modulators: From AMPA receptors to synapses and behavior. Curr Drug Targets 2007; 8:583-602
20. Lynch G: Glutamate-based therapeutic approaches: Ampakines. Curr Opin Pharmacol 2006; 6:82-8
21. Lynch G, Gall CM: Ampakines and the threefold path to cognitive enhancement. Trends Neurosci 2006; 29:554-62
22. Tuominen HJ, Tiihonen J, Wahlbeck K: Glutamatergic drugs for schizophrenia: A systematic review and meta-Analysis. Schizophr Res 2005; 72:225-34
23. Skolnick P, Popik P, Trullas R: Glutamate-based antidepressants: 20 years on. Trends Pharmacol Sci 2009; 30:563-9
24. Zheng YW, Balabhadrapatruni S, Masumura C, Darlington CL, Smith PF: Effects of the putative cognitive-enhancing ampakine, CX717, on attention and object recognition memory. Curr Alzheimer Res 2011; 8:876-82
25. Simmons DA, Rex CS, Palmer L, Pandyarajan V, Fedulov V, Gall CM, Lynch G: Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice. Proc Natl Acad Sci U S A 2009; 106:4906-11
26. Ren J, Ding X, Funk GD, Greer JJ: Ampakine CX717 protects against fentanyl-induced respiratory depression and lethal apnea in rats. Anest hesiolo gy 2009; 110:1364-70
27. Ren J, Poon BY, Tang Y, Funk GD, Greer JJ: Ampakines alleviate respiratory depression in rats. Am J Respir Crit Care Med 2006; 174:1384-91
28. Oertel BG, Felden L, Tran PV, Bradshaw MH, Angst MS, Schmidt H, Johnson S, Greer JJ, Geisslinger G, Varney MA, Lötsch J: Selective antagonism of opioid-induced ventilatory depression by an ampakine molecule in humans without loss of opioid analgesia. Clin Pharmacol Ther 2010; 87:204-11
29. Decosterd I, Woolf CJ: Spared nerve injury: An animal model of persistent peripheral neuropathic pain. Pain 2000; 87:149-58
30. Ruda MA, Iadarola MJ, Cohen LV, Young WS 3rd: In situ hybridization histochemistry and immunocytochemistry reveal an increase in spinal dynorphin biosynthesis in a rat model of peripheral inflammation and hyperalgesia. Proc Natl Acad Sci U S A 1988; 85:622-6
31. Iadarola MJ, Brady LS, Draisci G, Dubner R: Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: Stimulus specificity, behavioral parameters and opioid receptor binding. Pain 1988; 35:313-26
32. Nagarajan N, Quast C, Boxall AR, Shahid M, Rosenmund C: Mechanism and impact of allosteric AMPA receptor modulation by the ampakine CX546. Neuropharmacology 2001; 41:650-63
33. Ogier M, Wang H, Hong E, Wang Q, Greenberg ME, Katz DM: Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome. J Neurosci 2007; 27:10912-7
34. Silverman JL, Oliver CF, Karras MN, Gastrell PT, Crawley JN: AMPAKINE enhancement of social interaction in the BTBR mouse model of autism. Neuropharmacology 2013; 64:268-82
35. Procaccini C, Aitta-Aho T, Jaako-Movits K, Zharkovsky A, Panhelainen A, Sprengel R, Linden AM, Korpi ER: Excessive novelty-induced c-Fos expression and altered neurogenesis in the hippocampus of GluA1 knockout mice. Eur J Neurosci 2011; 33:161-74
36. Arai A, Kessler M, Rogers G, Lynch G: Effects of a memory-enhancing drug on dl-Alpha-Amino-3-hydroxy-5-methyl- 4-isoxazolepropionic acid receptor currents and synaptic transmission in hippocampus. J Pharmacol Exp Ther 1996; 278:627-38
37. Lynch G, Kessler M, Rogers G, Ambros-Ingerson J, Granger R, Schehr RS: Psychological effects of a drug that facilitates brain AMPA receptors. Int Clin Psychopharmacol 1996; 11:13-9
38. Bourquin AF, Süveges M, Pertin M, Gilliard N, Sardy S, Davison AC, Spahn DR, Decosterd I: Assessment and analysis of mechanical allodynia-like behavior induced by spared nerve injury (SNI) in the mouse. Pain 2006; 122:14.e1-14
39. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL: Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994; 53:55-63
40. H ao JX, Shi TJ, Xu IS, Kaupilla T, Xu XJ, Hökfelt T, Bartfai T, Wiesenfeld-Hallin Z: Intrathecal galanin alleviates allodynialike behaviour in rats after partial peripheral nerve injury. Eur J Neurosci 1999; 11:427-32
41. Jørum E, Warncke T, Stubhaug A: Cold allodynia and hyperalgesia in neuropathic pain: The effect of N-methyl-d-Aspartate (NMDA) receptor antagonist ketamine-A double-blind, crossover comparison with alfentanil and placebo. Pain 2003; 101:229-35
42. Wang J, Goffer Y, Xu D, Tukey DS, Shamir DB, Eberle SE, Zou AH, Blanck TJ, Ziff EB: A single subanesthetic dose of ketamine relieves depression-like behaviors induced by neuropathic pain in rats. Anest hesiolo gy 2011; 115:812-21
43. Cabeza de Vaca S, Carr KD: Food restriction enhances the central rewarding effect of abused drugs. J Neurosci 1998; 18:7502-10
44. G offer Y, Xu D, Eberle SE, D'amour J, Lee M, Tukey D, Froemke RC, Ziff EB, Wang J: Calcium-permeable AMPA receptors in the nucleus accumbens regulate depression-like behaviors in the chronic neuropathic pain state. J Neurosci 2013; 33:19034-44
45. Nestler EJ, Hyman SE: Animal models of neuropsychiatric disorders. Nat Neurosci 2010; 13:1161-9
46. von Hehn CA, Baron R, Woolf CJ: Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron 2012; 73:638-52
47. G reer JJ, Smith JC, Feldman JL: Role of excitatory amino acids in the generation and transmission of respiratory drive in neonatal rat. J Physiol 1991; 437:727-49
48. Funk GD, Smith JC, Feldman JL: Generation and transmission of respiratory oscillations in medullary slices: Role of excitatory amino acids. J Neurophysiol 1993; 70:1497-515
49. Pace RW, Mackay DD, Feldman JL, Del Negro CA: Inspiratory bursts in the preBötzinger complex depend on a calciumactivated non-specific cation current linked to glutamate receptors in neonatal mice. J Physiol 2007; 582(pt 1):113-25
50. G reer JJ, Ren J: Ampakine therapy to counter fentanylinduced respiratory depression. Respir Physiol Neurobiol 2009; 168:153-7
51. Ren J, Lenal F, Yang M, Ding X, Greer JJ: Coadministration of the AMPAKINE CX717 with propofol reduces respiratory depression and fatal apneas. Anest hesiolo gy 2013; 118:1437-45
52. Fields HL, Anderson SD, Clanton CH, Basbaum AI: Nucleus raphe magnus: A common mediator of opiate- and stimulus-produced analgesia. Trans Am Neurol Assoc 1976; 101:208-10
53. Basbaum AI, Fields HL: Endogenous pain control systems: Brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 1984; 7:309-38
54. H einricher MM, Tavares I, Leith JL, Lumb BM: Descending control of nociception: Specificity, recruitment and plasticity. Brain Res Rev 2009; 60:214-25
55. Morgan MM, Whittier KL, Hegarty DM, Aicher SA: Periaqueductal gray neurons project to spinally projecting GABAergic neurons in the rostral ventromedial medulla. Pain 2008; 140:376-86
56. Behbehani MM, Fields HL: Evidence that an excitatory connection between the periaqueductal gray and nucleus raphe magnus mediates stimulation produced analgesia. Brain Res 1979; 170:85-93
57. Jensen TS, Yaksh TL: Spinal monoamine and opiate systems partly mediate the antinociceptive effects produced by glutamate at brainstem sites. Brain Res 1984; 321:287-97
58. Urca G, Nahin RL, Liebeskind JC: Glutamate-induced analgesia: Blockade and potentiation by naloxone. Brain Res 1980; 192:523-30
59. G uan Y, Guo W, Zou SP, Dubner R, Ren K: Inflammationinduced upregulation of AMPA receptor subunit expression in brain stem pain modulatory circuitry. Pain 2003; 104:401-13
60. G uan Y, Guo W, Robbins MT, Dubner R, Ren K: Changes in AMPA receptor phosphorylation in the rostral ventromedial medulla after inflammatory hyperalgesia in rats. Neurosci Lett 2004; 366:201-5
61. H o YC, Cheng JK, Chiou LC: Hypofunction of glutamatergic neurotransmission in the periaqueductal gray contributes to nerve-injury-induced neuropathic pain. J Neurosci 2013; 33:7825-36
62. G uan Y, Terayama R, Dubner R, Ren K: Plasticity in excitatory amino acid receptor-mediated descending pain modulation after inflammation. J Pharmacol Exp Ther 2002; 300:513-20
63. Park JS, Voitenko N, Petralia RS, Guan X, Xu JT, Steinberg JP, Takamiya K, Sotnik A, Kopach O, Huganir RL, Tao YX: Persistent inflammation induces GluR2 internalization via NMDA receptor-triggered PKC activation in dorsal horn neurons. J Neurosci 2009; 29:3206-19
64. Li XY, Ko HG , Chen T, Descalzi G, Koga K, Wang H, Kim SS, Shang Y, Kwak C, Park SW, Shim J, Lee K, Collingridge GL, Kaang BK, Zhuo M: Alleviating neuropathic pain hypersensitivity by inhibiting PKMzeta in the anterior cingulate cortex. Science 2010; 330:1400-4
65. Ji G, Sun H, Fu Y, Li Z, Pais-Vieira M, Galhardo V, Neugebauer V: Cognitive impairment in pain through amygdala-driven prefrontal cortical deactivation. J Neurosci 2010; 30:5451-64
66. Montgomery KE, Kessler M, Arai AC: Modulation of agonist binding to AMPA receptors by 1-(1,4-benzodioxan-6-ylcarbonyl) piperidine (CX546): Differential effects across brain regions and GluA1-4/transmembrane AMPA receptor regulatory protein combinations. J Pharmacol Exp Ther 2009; 331:965-74
67. Dworkin RH, Gitlin MJ: Clinical aspects of depression in chronic pain patients. Clin J Pain 1991; 7:79-94
68. Miller LR, Cano A: Comorbid chronic pain and depression: Who is at risk? J Pain 2009; 10:619-27
69. Sanacora G, Treccani G, Popoli M: Towards a glutamate hypothesis of depression: An emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 2012; 62:63-77
70. Chandran A, Iyo AH, Jernigan CS, Legutko B, Austin MC, Karolewicz B: Reduced phosphorylation of the mTOR signaling pathway components in the amygdala of rats exposed to chronic stress. Prog Neuropsychopharmacol Biol Psychiatry 2013; 40:240-5
71. Duric V, Banasr M, Stockmeier CA, Simen AA, Newton SS, Overholser JC, Jurjus GJ, Dieter L, Duman RS: Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects. Int J Neuropsychopharmacol 2013; 16: 69-82
72. Y uen EY, Wei J, Liu W, Zhong P, Li X, Yan Z: Repeated stress causes cognitive impairment by suppressing glutamate receptor expression and function in prefrontal cortex. Neuron 2012; 73:962-77
73. Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M, Li XY, Aghajanian G, Duman RS: mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010; 329:959-64
74. Skolnick P: AMPA receptors: A target for novel antidepressants? Biol Psychiatry 2008; 63:347-8
75. Latremoliere A, Woolf CJ: Central sensitization: A generator of pain hypersensitivity by central neural plasticity. J Pain 2009; 10:895-926
76. Kessels HW, Malinow R: Synaptic AMPA receptor plasticity and behavior. Neuron 2009; 61:340-50
77. G onçalves L, Silva R, Pinto-Ribeiro F, Pêgo JM, Bessa JM, Pertovaara A, Sousa N, Almeida A: Neuropathic pain is associated with depressive behaviour and induces neuroplasticity in the amygdala of the rat. Exp Neurol 2008; 213:48-56
78. Kontinen VK, Kauppila T, Paananen S, Pertovaara A, Kalso E: Behavioural measures of depression and anxiety in rats with spinal nerve ligation-induced neuropathy. Pain 1999; 80:341-6
79. Suzuki T, Amata M, Sakaue G, Nishimura S, Inoue T, Shibata M, Mashimo T: Experimental neuropathy in mice is associated with delayed behavioral changes related to anxiety and depression. Anesth Analg 2007; 104:1570-7
80. Zeng Q, Wang S, Lim G, Yang L, Mao J, Sung B, Chang Y, Lim JA, Guo G, Mao J: Exacerbated mechanical allodynia in rats with depression-like behavior. Brain Res 2008; 1200:27-38
81. Kim H, Chen L, Lim G, Sung B, Wang S, McCabe MF, Rusanescu G, Yang L, Tian Y, Mao J: Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression. J Clin Invest 2012; 122:2940-54
82. Borges G, Neto F, Mico JA, Berrocoso E: Reversal of monoarthritis-induced affective disorders by diclofenac in rats. Anest hesiolo gy 2014; 120:1476-90